AM-Pharma Raises €29.2M In VC Financing

AM-Pharma, a biopharmaceutical company, has raised €29.2 million in series D venture capital financing. The investment round was led byYsios Capital Partnersand co-led byKurma Life Science Partners.

The fundraising process was supported by a consortium, including the venture arms of Abbott and Shire, as well as existing investorsForbion Capital PartnersandInventages Venture Capital.Joël Jean-Mairetof Ysios,Remi Drollerof Kurma Life Sciences Partners andKlaus BreinerofBB Biotech Ventureswill be joining the supervisory board of AM-Pharma.

Click here for the release fromBusiness Wire.